FORTIS:NSE
Fortis Healthcare Ltd
₹784.65
arrow_upward
+1.90%(+14.65) 1D
Oct 1, 3:30:00 PM GMT+5:30 · INR
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for FORTIS...
Open
₹763.00
High
₹786.40
Low
₹745.35
Mkt. cap
592.38B
Avg. vol.
1.34M
Volume
6.94M
Dividend
0.13%
Quarterly dividend
₹0.25
Ex-dividend date
Jul 24, 2026
P/E ratio
56.53
52-wk high
₹1,104.30
52-wk low
₹745.35
EPS
₹13.88
Shares outstanding
519.08M
No. of employees
15K
Open
₹763.00
High
₹786.40
Low
₹745.35
Mkt. cap
592.38B
Avg. vol.
1.34M
Volume
6.94M
Dividend
0.13%
Quarterly dividend
₹0.25
Ex-dividend date
Jul 24, 2026
P/E ratio
56.53
52-wk high
₹1,104.30
52-wk low
₹745.35
EPS
₹13.88
Shares outstanding
519.08M
No. of employees
15K
News stories
From web sources and news partners
Profile
Fortis Healthcare Limited is an Indian for-profit private hospital network headquartered in Gurgaon.
The Fortis Memorial Research Institute in Gurgaon serves as the headquarters for Fortis Healthcare. In addition to its Gurgaon facility, Fortis Healthcare operates hospitals in the Delhi NCR, including locations in Faridabad, Noida, Vasant Kunj, and Shalimar Bagh, along with other facilities across India, Dubai, and Sri Lanka. The company currently manages 36 healthcare facilities. Wikipedia
About Fortis Healthcare Ltd
CEOAshutosh Raghuvanshi
Employees14.6K
Founded1996
HeadquartersGurugram, Haryana, India
SectorHealth care provider
Websitefortishealthcare.com
Last report
Aug 7, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹3.62 / ₹3.75
-3.42%miss
arrow_downward
Revenue / Est. (INR)
25.45B / 25.08B
+1.47%beat
arrow_upward
Fiscal Q1 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in INR | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 23.31B | 22.65B | 23.65B | 25.45B |
Cost of goods sold | 13.50B | 13.37B | -3.56B | 15.29B |
Cost of revenue | 13.50B | 13.37B | -3.56B | 15.29B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | - | - | 4.29B | - |
Operating expense | 5.31B | 5.42B | 23.22B | 6.01B |
Total operating expenses | 18.81B | 18.80B | 19.66B | 21.30B |
Operating income | 4.50B | 3.86B | 3.98B | 4.15B |
Other non operating income | 225.80M | 82.90M | -709.53M | 144.70M |
EBT including unusual items | 4.25B | 2.66B | 3.24B | 3.63B |
EBT excluding unusual items | 4.02B | 3.12B | 3.33B | 3.54B |
Income tax expense | 965.80M | 682.80M | 530.11M | 903.80M |
Effective tax rate | 22.70% | 25.70% | 16.35% | 24.89% |
Other operating expenses | 4.25B | 4.22B | 17.71B | 4.79B |
Net income | 3.22B | 1.94B | 2.66B | 2.66B |
Net profit margin | 13.81% | 8.55% | 11.24% | 10.47% |
Earnings per share | 4.02 | 3.02 | 3.66 | 3.62 |
Interest and investment income | - | - | 394.31M | - |
Interest expense | -748.80M | -857.40M | -402.06M | -804.40M |
Net interest expenses | -748.80M | -857.40M | -7.74M | -804.40M |
Depreciation and amortization charges | 1.06B | 1.20B | 1.22B | 1.22B |
EBITDA | 5.54B | 4.62B | 4.87B | 5.04B |
Gain or loss from assets sale | - | - | - | - |